HEPACAM and hepatocellular carcinoma: Previous studies have shown that the expression of hepaCAM is frequently completely suppressed in human hepatocellular carcinoma and significantly suppressed in a variety of other tumor types including malignancies of the lung, brain, colon, and blood.